Advances in the Management of Severe and Life-Threatening Chemotoxicity.

Slides:

Advertisements

Similar presentations

Better care for Individuals Better health for Populations Lower Cost.

Advertisements

BCOM 405 Week 5 Learning Team Risk Management Presentation Prepare a slide PowerPoint® presentation (including speaker notes) in which you: a. Identify.

What's New in Basal Insulin for Diabetes

PPM+ and the Leeds Care Record The support and delivery of Personalised Medicine Dr Geoff Hall Senior Lecturer in Medical Oncology Chief Clinical Information.

Multimodal Management of Opioid-Induced Constipation

Upfront Combination Therapy vs Step-Up Approach for PAH:

The Patient Experience With Systemic Lupus Erythematosus

The Nurse View: Management of Pancreatic Cancer

Silent No More:.

COPD by the Guidelines.

Primary Care Challenges in Depression - To Treat or Refer?

NOACs for Cancer-Associated Thrombosis:

Making Decisions With Your Osteoarthritis Patients

Optimizing Therapy for Osteoarthritis

Cardiogenic Shock.

The Clinical Enigma of Cardiogenic Shock

Best Practices in Huntington Disease

PrEP Effectiveness. Preexposure Prophylaxis Translating the Clinical Trials Into Clinical Practice.

Modifying Disease Course in Alzheimer's Disease

Progression After Cancer Immunotherapy in Advanced NSCLC

Current Controversies in Multiple Sclerosis Management

Understanding the Many Faces of Pseudobulbar Affect

Epidemiology Venous Pathophysiology Etiology.

New Standards of Care in ALK-Translocated Advanced NSCLC

American Heart Association Scientific Sessions

The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer

Clinical Presentations of VTEa,b NOACs VTE Acute Treatment Trials.

Statin Selection in Special Patient Populations: A Case Challenge

Clinical Considerations in Evidence-based Management of GIST

Chronic Idiopathic Urticaria

Program Goals. The Role of Chemotherapy in Improving Quality of Life in Advanced NSCLC.

How Can we Improve Outcomes for the Elderly Patient with AML?

When Would You Use Single Inhaler Triple Therapy in COPD?

The Evolving Role of Immunotherapy in NSCLC

Decision-making in the eRA of Treating to Target

Improving Risk Assessment and Early Diagnosis in PAH

Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.

Dispelling Myths and Misconceptions ACC/AHA 2013 Digoxin Guidelines for Heart Failure.

Are We Closer to Personalized Medicine in MS?

From Symptom Management to Communication in Advanced GI Cancers

TAVR and the Risk of Thrombosis

Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?

Gene Therapy: Past, Present, and Future

Extending Treatment for Thrombosis: What’s the Right Choice?

Translating the Latest and Greatest Advances in PAH Into Clinical Practice.

EARLY Combination Therapy in PAH: What Every Cardiologist Needs to Know.

Hyperammonemia: Best Practices for Diagnosis and Treatment

Preventing Clinical Events in PAH

5 Things You Need to Know About Hypoparathyroidism

After the Baby Comes.

Treatment-Resistant Schizophrenia

New Strategies to Reduce HF Readmissions

Managing HF in Primary Care

Are We Making Progress in the Management of Huntington Disease?

VOD/SOS: Aligned Education for Patients and the Interprofessional Team

Incorporating Prostacyclins Into Practice

Challenges in LA SCCHN.

Strengthening Lung Cancer Team Connections to Improve Outcomes With Immunotherapy.

When Good Isn't Good Enough

What is “AF Burden”?. What is “AF Burden”? AF Burden and Stroke Risk ASSERT Study.

Life-Threatening Chemotoxicity

Checkpoint Inhibitors in First-Line Advanced NSCLC

Clinical Considerations in Evidence-based Management of GIST

MS, Age, and Immune Function

New Options for the Treatment of Hepatocellular Carcinoma

Anemia Explored.

My PAH Patient.

Rethinking Risk Stratification for Nonischemic HF:

Foundations of Asthma.

Navigating the Journey

Presentation transcript:

Advances in the Management of Severe and Life-Threatening Chemotoxicity

Chemotoxicities

Impact of Chemotoxicity

5-FU and Capecitabine Toxicity

5-FU and Capecitabine Toxicity (cont)

Risk Assessment

Risk Assessment (cont)

Symptoms and Signs of 5-FU Toxicity

Symptoms and Signs of 5-FU Toxicity (cont)a,b

How to Differentiate Severe 5-FU Toxicities

How to Differentiate Severe 5-FU Toxicities (cont)

Basic Management of 5-FU Toxicity

Uridine Triacetate

Uridine Triacetate: Clinical Trial Results

Uridine Triacetate: Clinical Trial Results (cont)

Uridine Triacetate Treatment: Indications

Roles of the Interdisciplinary Healthcare Team

Roles of the Interdisciplinary Healthcare Team (cont)

Roles of the Interdisciplinary Healthcare Team (cont)

Case Presentation

Case Presentation (cont)

Case Presentation (cont)

Take-Away Points

Abbreviations